A clinical trial of PMSC 11
Latest Information Update: 03 Jun 2024
At a glance
- Drugs PMSC 11 (Primary)
- Indications Liver failure
- Focus Adverse reactions
Most Recent Events
- 03 Jun 2024 New trial record
- 23 May 2024 According to a Immorta Bio Inc media release, company is planning with USFDA to begin clinical trials for PMSC-11, a personalized mesenchymal stem cell.